Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil
about
The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice.Intravenous Lipid Emulsions in Parenteral NutritionLow-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders.Complications associated with parenteral nutrition in the neonate.Preservation of biochemical liver function with low-dose soy-based lipids in children with intestinal failure-associated liver disease.Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children.Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease.Intestinal transplantation in children: current status.Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.Nutrition Deficiencies in Children With Intestinal Failure Receiving Chronic Parenteral Nutrition.Intravenous Fish Oil and Pediatric Intestinal Failure-Associated Liver Disease: Changes in Plasma Phytosterols, Cytokines, and Bile Acids and Erythrocyte Fatty Acids.Higher Doses of Fish Oil-Based Lipid Emulsions Used to Treat Inadequate Weight Gain and Rising Triene:Tetraene Ratio in a Severely Malnourished Infant With Intestinal Failure-Associated Liver Disease.Parenteral Soybean Oil Induces Hepatosteatosis Despite Addition of Fish Oil in a Mouse Model of Intestinal Failure-Associated Liver Disease.The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome.Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy.
P2860
Q34778491-04C5F315-0628-4986-876B-CB588CBB9C0AQ36033721-D6798C07-9225-4FBD-A99C-48ED2214534BQ36328532-6204FB71-F7DF-42C5-B227-21CA0CF89EBFQ37742150-118DD82D-562F-4AD4-9B33-A665A47B9488Q38365111-EDB1936C-7E16-4160-985D-C682439C6F06Q38704646-6C5F4CEC-EFCE-4BA8-98B4-773BC22881CAQ38768064-201D44C0-09E9-480E-B591-B2865EEA75CDQ38795139-3D513480-33DB-4D79-88C4-DC0355AE9531Q39502863-E4390CD1-EBF0-4C70-A23A-EB4FC40CF7EFQ46106509-39E7959B-7F2D-420C-9136-94E9D7D6FE34Q46631846-CB1185AF-14CB-4D84-B07B-DC84A69DA00FQ47284245-2EC71382-99C0-4617-A812-FD1DA5BAC7EAQ47396256-A0D2DB94-FE3C-49AF-BFE8-0D1716637C62Q50077952-6DD2B7D0-823D-4C7C-AC27-4AC2D23D6BAAQ53242051-B240C874-204D-4CC5-ADD9-B49D35F843E8
P2860
Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Pediatric intestinal failure-a ...... months of intravenous fish oil
@ast
Pediatric intestinal failure-a ...... months of intravenous fish oil
@en
Pediatric intestinal failure-a ...... months of intravenous fish oil
@nl
type
label
Pediatric intestinal failure-a ...... months of intravenous fish oil
@ast
Pediatric intestinal failure-a ...... months of intravenous fish oil
@en
Pediatric intestinal failure-a ...... months of intravenous fish oil
@nl
prefLabel
Pediatric intestinal failure-a ...... months of intravenous fish oil
@ast
Pediatric intestinal failure-a ...... months of intravenous fish oil
@en
Pediatric intestinal failure-a ...... months of intravenous fish oil
@nl
P2093
P2860
P356
P1476
Pediatric intestinal failure-a ...... months of intravenous fish oil
@en
P2093
Douglas G Farmer
James C Y Dunn
Laurie Reyen
Robert S Venick
Sherin U Devaskar
Stephen B Shew
P2860
P304
P356
10.1177/0148607113495416
P577
2013-07-26T00:00:00Z